Intellia Therapeutics, Inc. to Post Q3 2024 Earnings of ($1.36) Per Share, Wedbush Forecasts (NASDAQ:NTLA)

Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) – Wedbush lowered their Q3 2024 earnings estimates for Intellia Therapeutics in a report issued on Thursday, August 8th. Wedbush analyst D. Nierengarten now forecasts that the company will post earnings of ($1.36) per share for the quarter, down from their previous estimate of ($1.14). Wedbush currently has […]

Leave a Reply

Your email address will not be published.

Previous post Analysts Set Expectations for Passage Bio, Inc.’s Q3 2024 Earnings (NASDAQ:PASG)
Next post Monroe Capital Co. Forecasted to Earn Q3 2024 Earnings of $0.31 Per Share (NASDAQ:MRCC)